Le Lézard
Classified in: Health
Subjects: STP, AVO

Science Must Drive Clinical Practice, Public Health Policy


ALISO VIEJO, Calif., Sept. 30, 2020 /PRNewswire/ -- Newswise -- The American Association of Critical-Care Nurses (AACN) has released a position statement calling for all healthcare decision-making to be anchored in the best scientific evidence available. The statement, "Science Must Drive Clinical Practice and Public Health Policy," reinforces nursing professionals' commitment to following the best evidence possible to provide care for patients and families.

"It is vital for our work to be guided by evidence," said AACN President Elizabeth Bridges, PhD, RN, CCNS, FCCM, FAAN. She is professor, Biobehavioral Nursing and Health Systems at the University of Washington School of Nursing, Seattle, and clinical nurse researcher at the University of Washington Medical Center. "We must also be willing to innovate, yet thoughtfully and efficiently test changes to find the safest and most effective approaches to patient care and health policy."

The AACN position statement outlines several recommended actions for nurses and healthcare policymakers.

Recommended actions for nurses include:

Recommended actions for healthcare policymakers include:

"During times darkened by fear of disease and mistrust of science, nurses must mark a bright line between evidence-based healthcare guidance and opinions based on economic expediency or political ideology," the statement notes. "Even when fast-moving public health crises make it impossible to find sufficient amounts of peer-reviewed research, public policy decisions must be based on carefully evaluated healthcare information and the guidance of fully qualified experts."

Read the full statement online.

About the American Association of Critical-Care Nurses: For more than 50 years, the American Association of Critical-Care Nurses (AACN) has been dedicated to acute and critical care nursing excellence. The organization's vision is to create a healthcare system driven by the needs of patients and their families in which acute and critical care nurses make their optimal contribution. AACN is the world's largest specialty nursing organization, with more than 120,000 members and over 200 chapters in the United States.

American Association of Critical-Care Nurses, 27071 Aliso Creek Road, Aliso Viejo, CA 92656; 949-362-2000; www.aacn.org; facebook.com/aacnface; twitter.com/aacnme

Provided by Newswise, online resource for knowledge-based news at www.newswise.com

Media Contacts: Kristie Aylett
AACN Communications
228-229-9472
[email protected]

SOURCE American Association of Critical-Care Nurses (AACN)


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: